These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 31889490)

  • 21. Genetic Diversity, Compartmentalization, and Age of HIV Proviruses Persisting in CD4
    Jones BR; Miller RL; Kinloch NN; Tsai O; Rigsby H; Sudderuddin H; Shahid A; Ganase B; Brumme CJ; Harris M; Poon AFY; Brockman MA; Fromentin R; Chomont N; Joy JB; Brumme ZL
    J Virol; 2020 Feb; 94(5):. PubMed ID: 31776273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lack of concordance between residual viremia and viral variants driving de novo infection of CD4(+) T cells on ART.
    Puertas MC; Noguera-Julian M; Massanella M; Pou C; Buzon MJ; Clotet B; Stevenson M; Paredes R; Blanco J; Martinez-Picado J
    Retrovirology; 2016 Aug; 13(1):51. PubMed ID: 27484989
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assays to Measure Latency, Reservoirs, and Reactivation.
    Siliciano JD; Siliciano RF
    Curr Top Microbiol Immunol; 2018; 417():23-41. PubMed ID: 29071475
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluating the Intactness of Persistent Viral Genomes in Simian Immunodeficiency Virus-Infected Rhesus Macaques after Initiating Antiretroviral Therapy within One Year of Infection.
    Long S; Fennessey CM; Newman L; Reid C; O'Brien SP; Li Y; Del Prete GQ; Lifson JD; Gorelick RJ; Keele BF
    J Virol; 2019 Dec; 94(1):. PubMed ID: 31597776
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic Approaches to Eradicate Latent HIV-1 in Resting CD4+ T Cells.
    Sluis-Cremer N
    Curr Top Med Chem; 2016; 16(10):1191-7. PubMed ID: 26324046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modeling HIV-1 Latency Using Primary CD4
    Takata H; Kessing C; Sy A; Lima N; Sciumbata J; Mori L; Jones RB; Chomont N; Michael NL; Valente S; Trautmann L
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30918072
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV-1 latent reservoir size and diversity are stable following brief treatment interruption.
    Salantes DB; Zheng Y; Mampe F; Srivastava T; Beg S; Lai J; Li JZ; Tressler RL; Koup RA; Hoxie J; Abdel-Mohsen M; Sherrill-Mix S; McCormick K; Overton ET; Bushman FD; Learn GH; Siliciano RF; Siliciano JM; Tebas P; Bar KJ
    J Clin Invest; 2018 Jul; 128(7):3102-3115. PubMed ID: 29911997
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Short Communication: The Broad-Spectrum Histone Deacetylase Inhibitors Vorinostat and Panobinostat Activate Latent HIV in CD4(+) T Cells In Part Through Phosphorylation of the T-Loop of the CDK9 Subunit of P-TEFb.
    Jamaluddin MS; Hu PW; Jan Y; Siwak EB; Rice AP
    AIDS Res Hum Retroviruses; 2016 Feb; 32(2):169-73. PubMed ID: 26727990
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Longitudinal clonal dynamics of HIV-1 latent reservoirs measured by combination quadruplex polymerase chain reaction and sequencing.
    Cho A; Gaebler C; Olveira T; Ramos V; Saad M; Lorenzi JCC; Gazumyan A; Moir S; Caskey M; Chun TW; Nussenzweig MC
    Proc Natl Acad Sci U S A; 2022 Jan; 119(4):. PubMed ID: 35042816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo analysis of the effect of panobinostat on cell-associated HIV RNA and DNA levels and latent HIV infection.
    Tsai P; Wu G; Baker CE; Thayer WO; Spagnuolo RA; Sanchez R; Barrett S; Howell B; Margolis D; Hazuda DJ; Archin NM; Garcia JV
    Retrovirology; 2016 May; 13(1):36. PubMed ID: 27206407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myeloid and CD4 T Cells Comprise the Latent Reservoir in Antiretroviral Therapy-Suppressed SIVmac251-Infected Macaques.
    Abreu CM; Veenhuis RT; Avalos CR; Graham S; Parrilla DR; Ferreira EA; Queen SE; Shirk EN; Bullock BT; Li M; Metcalf Pate KA; Beck SE; Mangus LM; Mankowski JL; Mac Gabhann F; O'Connor SL; Gama L; Clements JE
    mBio; 2019 Aug; 10(4):. PubMed ID: 31431552
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between intact HIV-1 proviruses in circulating CD4
    Lu CL; Pai JA; Nogueira L; Mendoza P; Gruell H; Oliveira TY; Barton J; Lorenzi JCC; Cohen YZ; Cohn LB; Klein F; Caskey M; Nussenzweig MC; Jankovic M
    Proc Natl Acad Sci U S A; 2018 Nov; 115(48):E11341-E11348. PubMed ID: 30420517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Resting CD4+ T lymphocytes but not thymocytes provide a latent viral reservoir in a simian immunodeficiency virus-Macaca nemestrina model of human immunodeficiency virus type 1-infected patients on highly active antiretroviral therapy.
    Shen A; Zink MC; Mankowski JL; Chadwick K; Margolick JB; Carruth LM; Li M; Clements JE; Siliciano RF
    J Virol; 2003 Apr; 77(8):4938-49. PubMed ID: 12663799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of 5' LTR DNA methylation of latent HIV-1 provirus in cell line models and in long-term-infected individuals.
    Trejbalová K; Kovářová D; Blažková J; Machala L; Jilich D; Weber J; Kučerová D; Vencálek O; Hirsch I; Hejnar J
    Clin Epigenetics; 2016; 8():19. PubMed ID: 26900410
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measuring integrated HIV DNA ex vivo and in vitro provides insights about how reservoirs are formed and maintained.
    Pinzone MR; O'Doherty U
    Retrovirology; 2018 Feb; 15(1):22. PubMed ID: 29452580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expanded cellular clones carrying replication-competent HIV-1 persist, wax, and wane.
    Wang Z; Gurule EE; Brennan TP; Gerold JM; Kwon KJ; Hosmane NN; Kumar MR; Beg SA; Capoferri AA; Ray SC; Ho YC; Hill AL; Siliciano JD; Siliciano RF
    Proc Natl Acad Sci U S A; 2018 Mar; 115(11):E2575-E2584. PubMed ID: 29483265
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Impact of Cellular Proliferation on the HIV-1 Reservoir.
    Virgilio MC; Collins KL
    Viruses; 2020 Jan; 12(2):. PubMed ID: 31973022
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Concurrent administration of IFNα14 and cART in TKO-BLT mice enhances suppression of HIV-1 viremia but does not eliminate the latent reservoir.
    Sutter K; Lavender KJ; Messer RJ; Widera M; Williams K; Race B; Hasenkrug KJ; Dittmer U
    Sci Rep; 2019 Dec; 9(1):18089. PubMed ID: 31792317
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dynamic Shifts in the HIV Proviral Landscape During Long Term Combination Antiretroviral Therapy: Implications for Persistence and Control of HIV Infections.
    Anderson EM; Simonetti FR; Gorelick RJ; Hill S; Gouzoulis MA; Bell J; Rehm C; Pérez L; Boritz E; Wu X; Wells D; Hughes SH; Rao V; Coffin JM; Kearney MF; Maldarelli F
    Viruses; 2020 Jan; 12(2):. PubMed ID: 31991737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heterogeneity of HIV-1 latent reservoirs.
    Zhao JC; Deng K
    Chin Med J (Engl); 2020 Dec; 133(23):2867-2873. PubMed ID: 33273337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.